Learn from experienced investors and entrepreneurs how best to position your company for funding in today’s uncertain world. How do you obtain proof of concept funding in this market? Has the venture capital investing model changed? Are alternative sources of capital and investing models emerging?
Moderator: Gabor Garai
Panelists:
- Shawn Broderick, Executive Director, TechStars Boston
- Paul Maeder, General Partner, Highland Capital Partners
- Nina Saberi, Managing General Partner, Castile Ventures
- Michael Skok, General Partner, North Bridge Venture Partners
Related Insights
April 15, 2026
Foley Viewpoints
Key Health Care Enforcement Trends Under the Trump Administration: FCA, Data Analytics, and Emerging Risk Areas
These trends included (i) an enduring focus on waste, fraud, and abuse in the health care industry; (ii) a continued focus on Medicare Advantage and a newer focus on gender transition procedures for minors; and (iii) the ever-increasing use of data analytics to prosecute cases.
April 14, 2026
Health Care Law Today
FDA Clarifies Policies for Pharmacy Compounders of GLP-1 Products
On April 1, 2026,the U.S. Food & Drug Administration (FDA) issued a statement clarifying its compliance policy on the conditions that must be met for compounded drugs to qualify for the exemptions under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
April 14, 2026
Foley Career Perspectives
Trust Your Instincts: Susan Pravda on Leadership, Relationships, and Resilience
Foley partner Susan Pravda is a business lawyer focused on mergers and acquisitions, venture capital, initial public offerings, and related securities transactions and is head of Foley’s Health Care & Life Sciences Sector. She also serves as the firm’s chief strategic talent acquisition partner.